Stock listing
NASDAQ:RARE Ultragenyx Pharmaceutical Inc. Stock
Home listing (NASDAQ) of Ultragenyx Pharmaceutical Inc.
Follow Ultragenyx Pharmaceutical Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RARE
$15.57 USD -1.59 (-9.3%)
Close on Nov 5, 2026
- Day range
- $15.49 – $17.12 USDNov 5, 2026
- Volume
- 5.38M sharesNov 5, 2026
- Market cap
- $1.54B USDAt the close on Nov 5, 2026 · price × 98.59M shares outstanding
- 52-week range
- $12.73 – $39.89 USDLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- $73.64M USDMedian day 3.60M shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RARE · Home | $15.57 USD | -1.59 (-9.3%) | 5,383,215 | $17.07 | $17.12 | $15.49 | $17.16 | Close on Nov 5, 2026 |
| LSE:0LIF | $15.89 USD | -0.878 (-5.2%) | 4,457 | $17.20 | $17.41 | $15.88 | $16.77 | Close on Nov 5, 2026 |
| Frankfurt:UP0 | €15.11 EUR | +0.875 (+6.1%) | — | €15.11 | €15.11 | €15.11 | €14.24 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:RARE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.57 | -1.59 | -9.3% | $17.07 | $17.12 | $15.49 | 5,383,215 | |
| $17.16 | +0.53 | +3.2% | $17.04 | $17.67 | $16.23 | 7,330,565 | |
| $16.63 | +0.33 | +2.0% | $16.52 | $16.99 | $16.39 | 3,671,217 | |
| $16.30 | +0.20 | +1.2% | $16.29 | $16.44 | $15.85 | 4,840,905 | |
| $16.10 | -0.68 | -4.1% | $16.64 | $16.93 | $15.92 | 2,333,527 | |
| $16.78 | -0.42 | -2.4% | $17.26 | $17.63 | $16.71 | 2,801,874 | |
| $17.20 | +0.45 | +2.7% | $16.73 | $17.35 | $16.47 | 2,319,744 | |
| $16.75 | +0.67 | +4.2% | $16.05 | $16.96 | $15.88 | 4,943,979 | |
| $16.08 | +0.43 | +2.7% | $15.77 | $16.22 | $15.60 | 3,022,884 | |
| $15.65 | -0.30 | -1.9% | $15.92 | $15.94 | $15.49 | 1,789,100 | |
| $15.95 | +0.03 | +0.2% | $15.78 | $16.25 | $15.60 | 2,374,100 | |
| $15.92 | -0.10 | -0.6% | $16.02 | $16.31 | $15.79 | 2,825,000 | |
| $16.02 | +0.95 | +6.3% | $15.01 | $16.27 | $14.99 | 3,546,000 | |
| $15.07 | +0.53 | +3.6% | $14.67 | $15.08 | $14.54 | 2,984,400 | |
| $14.54 | -0.63 | -4.2% | $15.11 | $15.21 | $14.44 | 2,924,000 | |
| $15.17 | +0.27 | +1.8% | $14.87 | $15.37 | $14.79 | 3,332,000 | |
| $14.90 | -0.02 | -0.1% | $14.93 | $15.18 | $14.67 | 2,953,000 | |
| $14.92 | -0.38 | -2.5% | $15.27 | $15.39 | $14.69 | 5,305,200 | |
| $15.30 | -0.18 | -1.2% | $15.42 | $15.49 | $15.10 | 2,898,600 | |
| $15.48 | +0.19 | +1.2% | $15.30 | $15.73 | $15.23 | 2,927,600 | |
| $15.29 | +0.40 | +2.7% | $14.79 | $15.52 | $14.43 | 5,396,500 | |
| $14.89 | +0.43 | +3.0% | $14.37 | $15.25 | $14.35 | 4,162,500 | |
| $14.46 | -0.04 | -0.3% | $14.60 | $14.70 | $14.08 | 3,892,000 | |
| $14.50 | -0.72 | -4.7% | $15.25 | $15.31 | $14.21 | 4,656,500 | |
| $15.22 | +0.47 | +3.2% | $14.90 | $15.28 | $14.67 | 3,880,500 | |
| $14.75 | -0.28 | -1.9% | $15.03 | $15.25 | $14.62 | 4,116,000 | |
| $15.03 | -0.29 | -1.9% | $15.48 | $15.53 | $14.86 | 4,421,200 | |
| $15.32 | +0.91 | +6.3% | $14.46 | $15.50 | $14.11 | 5,884,600 | |
| $14.41 | -0.09 | -0.6% | $14.33 | $14.47 | $14.11 | 4,939,900 | |
| $14.50 | -0.27 | -1.8% | $14.87 | $14.94 | $14.15 | 4,303,700 | |
| $14.77 | -0.11 | -0.7% | $14.73 | $14.87 | $14.55 | 3,488,700 | |
| $14.88 | -0.735 | -4.7% | $15.40 | $15.50 | $14.54 | 5,704,900 | |
| $15.62 | +0.965 | +6.6% | $14.78 | $16.12 | $14.48 | 8,134,200 | |
| $14.65 | +0.14 | +1.0% | $14.58 | $15.01 | $14.28 | 5,269,500 | |
| $14.51 | +0.01 | +0.1% | $14.79 | $15.07 | $14.07 | 13,328,100 | |
| $14.50 | +1.62 | +12.6% | $13.22 | $14.58 | $13.20 | 12,427,800 | |
| $12.88 | -0.19 | -1.5% | $13.07 | $13.22 | $12.73 | 5,031,200 | |
| $13.07 | -0.54 | -4.0% | $13.56 | $13.59 | $12.88 | 5,655,000 | |
| $13.61 | -0.69 | -4.8% | $14.44 | $14.44 | $13.60 | 5,929,200 | |
| $14.30 | -0.10 | -0.7% | $14.43 | $14.70 | $14.13 | 3,252,100 | |
| $14.40 | +0.09 | +0.6% | $14.25 | $14.44 | $13.95 | 3,659,800 | |
| $14.31 | -0.57 | -3.8% | $14.77 | $15.20 | $14.27 | 4,573,600 | |
| $14.88 | -0.42 | -2.7% | $15.10 | $15.25 | $14.63 | 5,926,500 | |
| $15.30 | +0.45 | +3.0% | $15.48 | $16.08 | $15.23 | 11,494,500 | |
| $14.85 | -11.68 | -44.0% | $14.00 | $15.00 | $13.81 | 27,159,700 | |
| $26.53 | +0.72 | +2.8% | $25.96 | $26.80 | $25.57 | 7,170,800 | |
| $25.81 | +0.60 | +2.4% | $25.22 | $25.85 | $25.11 | 1,871,300 | |
| $25.21 | -0.40 | -1.6% | $25.45 | $25.90 | $24.73 | 1,934,100 | |
| $25.61 | -0.65 | -2.5% | $26.54 | $26.73 | $25.37 | 1,612,600 | |
| $26.26 | -0.18 | -0.7% | $26.38 | $26.56 | $25.83 | 1,142,600 | |
| $26.44 | -0.02 | -0.1% | $26.55 | $26.67 | $25.61 | 1,666,100 | |
| $26.46 | +0.74 | +2.9% | $26.25 | $26.92 | $26.00 | 3,807,810 | |
| $25.72 | -0.11 | -0.4% | $25.75 | $26.09 | $25.30 | 1,536,973 | |
| $25.83 | +0.51 | +2.0% | $25.76 | $26.75 | $25.69 | 2,392,300 | |
| $25.32 | -0.92 | -3.5% | $28.39 | $28.50 | $25.04 | 3,841,100 | |
| $26.24 | +0.75 | +2.9% | $26.28 | $26.68 | $26.00 | 2,846,600 | |
| $25.49 | -0.64 | -2.4% | $25.68 | $26.11 | $24.97 | 1,793,100 | |
| $26.13 | -0.36 | -1.4% | $26.26 | $26.51 | $25.81 | 1,315,700 | |
| $26.49 | +0.11 | +0.4% | $26.30 | $26.58 | $25.75 | 1,222,200 | |
| $26.38 | -0.48 | -1.8% | $27.07 | $27.17 | $26.33 | 946,100 | |
| $26.86 | -0.10 | -0.4% | $26.79 | $27.16 | $26.11 | 1,545,100 | |
| $26.96 | +0.16 | +0.6% | $27.16 | $27.59 | $26.42 | 2,138,800 | |
| $26.80 | +0.89 | +3.4% | $25.91 | $27.11 | $25.51 | 2,364,700 | |
| $25.91 | +0.09 | +0.3% | $26.34 | $26.71 | $25.30 | 3,829,200 | |
| $25.82 | +0.89 | +3.6% | $24.99 | $26.10 | $24.81 | 1,960,500 | |
| $24.93 | -0.88 | -3.4% | $28.48 | $28.48 | $24.61 | 2,642,400 |
- Ticker
- NASDAQ:RARE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Latest earnings call · Nov 3, 2026
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Apr 30, 2026
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides
Calls
Replays
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
Nov 3, 2026
Closed $17.16 (+3.2%) on Nov 4, 2026
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Oct 27, 2026
Closed $17.20 (+2.7%) on Oct 28, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
Oct 14, 2026
Closed $14.90 (-0.1%) on Oct 14, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
Oct 7, 2026
Closed $14.89 (+3.0%) on Oct 7, 2026
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Oct 2, 2026
Closed $15.22 (+3.2%) on Oct 2, 2026
Ultragenyx Announces Approval of FAYUVI Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A
Sep 18, 2026
Closed $14.51 (+0.1%) on Sep 18, 2026
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Sep 17, 2026
Closed $14.50 (+12.6%) on Sep 17, 2026
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
Sep 2, 2026
Closed $14.85 (-44.0%) on Sep 3, 2026
Decks
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides · Apr 30, 2026
Q4 2025 Earnings Presentation
Earnings · 46 slides · Feb 12, 2026
Q2 2025 Earnings Presentation
Earnings · 42 slides · Aug 5, 2025
Technical Presentation (October 2023)
Technical · 22 slides · Oct 16, 2023
Ultragenyx Pharmaceutical Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 35 in the last 12 months · 221 in all · newest Nov 6, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 3, 2026
- Decks
- 9 decks · latest Apr 30, 2026
Where Ultragenyx Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RARE · Home listing · This page | NASDAQ | United States | USD |
| LSE:0LIF | LSE | United Kingdom | USD |
| gettex:UP0 | gettex | Germany | EUR |
| BMV:RARE | BMV | Mexico | MXN |
| LS Exchange:A1XCY0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XCY0 | Lang & Schwarz | Germany | EUR |
| B3:R2AR34 | B3 | Brazil | BRL |
| BIVA:RARE | BIVA | Mexico | MXN |
| Frankfurt:UP0 | Frankfurt | Germany | EUR |
| Tradegate:UP0 | Tradegate | Germany | EUR |
| BOATS:RARE | BOATS | United States | USD |
| BX Swiss:UP0 | BX Swiss | Switzerland | CHF |
| Dusseldorf:UP0 | Dusseldorf | Germany | EUR |
| Hamburg:UP0 | Hamburg | Germany | EUR |
| Stuttgart:UP0 | Stuttgart | Germany | EUR |
| Hanover:UP0 | Hanover | Germany | EUR |
| Xetra:UP0 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Ultragenyx Pharmaceutical Inc.